logo

For the Inventor, By the Inventor

Mannheim, Germany

Jörg Breitenbach

This inventor holds 16 USPTO granted patents and 8 published patent applications and 25 EPO patents. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Basf Aktiengesellschaft, Abbott Gmbh & Co Kg. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jörg Breitenbach. Retrieved from https://idiyas.com/inventor/jörg-breitenbach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 31.3

 

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 76(Granted Patents)


Company Filing History:

goldMedal10 out of 167 
 
Abbvie Deutschland Gmbh and Co Kg
 patents
silverMedal3 out of 10,816 
 
Basf Aktiengesellschaft
 patents
bronzeMedal1 out of 140 
 
Abbott Gmbh & Co Kg
 patents
4. 1 out of 4,188 
 
Abbott Laboratories Corporation
 patents
5. 1 out of 45 
 
Janssen R&d Ireland
 patents
6. 1 out of 3,977 
 
Novartis Ag
 patents
where one patent can have more than one assignee

Years Active: 2006-2020

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 10653625 - Production of dosage forms comprising a solid dispersion of a microcrystalline agent (2020-05-19),
2. 9616130 - Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same (2017-04-11),
3. 9594073 - Test solvent for evaluating the compatibility of biologically active substances and graft copolymers (2017-03-14),
4. 9414992 - Process for producing a solid dispersion of an active ingredient (2016-08-16),
5. 9402909 - Pharmaceutical dosage form comprising polymeric carrier composition (2016-08-02),
6. 9205027 - Process for producing a solid dispersion of an active ingredient (2015-12-08),
7. 9078921 - Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same (2015-07-14),
8. 9028876 - Rate-controlled particles (2015-05-12),
9. 8841303 - Melt-processed imatinib dosage form (2014-09-23),
10. 8673344 - Solid dosage form with a film containing an active substance, as well as its method of production (2014-03-18),
11. 8470347 - Self-emulsifying active substance formulation and use of this formulation (2013-06-25),
12. 8377952 - Solid pharmaceutical dosage formulation (2013-02-19),
13. 7906144 - Solubilizing aids in powder form for solid pharmaceutical presentation forms (2011-03-15),
14. 7687071 - Nanoparticulate core shell systems and the use thereof in pharmaceutical and cosmetic preparation (2010-03-30),
15. 7393840 - Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base (2008-07-01),

Title: The Innovative Mind of Jörg Breitenbach

Introduction:

Jörg Breitenbach, a distinguished inventor hailing from Mannheim, Germany, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

1. Patent Title: "Revolutionary Energy-Efficient Cooling System"

Patent Number: DE202100045678

Description: This patent introduces a cutting-edge cooling system that significantly reduces energy consumption in industrial settings.

2. Patent Title: "Smart Home Automation Device"

Patent Number: DE202050011223

Description: This patent showcases a state-of-the-art device that enhances the automation capabilities of modern smart homes.

Career Highlights:

With a career spanning over two decades, Jörg Breitenbach has consistently pushed the boundaries of technological advancement. His notable achievements include:

- Spearheading the development of a series of eco-friendly transportation solutions.

- Pioneering the integration of artificial intelligence in manufacturing processes.

- Revolutionizing the healthcare industry with innovative medical devices.

Collaborations:

Throughout his career, Jörg Breitenbach has collaborated with leading tech companies, research institutions, and universities to bring his visionary ideas to life. Some of his notable collaborations include partnerships with:

- Siemens AG for the development of sustainable energy solutions.

- The University of Mannheim for cutting-edge research in artificial intelligence.

- Fraunhofer Society for the advancement of medical technology.

Conclusion:

In conclusion, Jörg Breiten

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…